Member Info for masterinvestors

Very, very prudent move Areas now being covered are massive

Positive to us... speeds up the drilling process, saves $7m Onwards from here..

GOING CONCERN The directors have reviewed the forward cash flow projections for the group for the foreseeable future, being at least the next 12 months from the date of this report, which show that the group has sufficient financial resources to undertake its committed work programme, and thus the directors have concluded that the group is a going concern They will have by tomorrow...���.

You sell to the people on the news when everyone wants them You buy stock when no one wants them Repeat after us.... You sell to the people on the news when everyone wants them You buy stock when no one wants them

fundraising @.45 to fund Portugal Disgrace

We must state that we have been having a dialogue with the Company and are pleased to confirm that; "The context of the European article is accurate being that Prof. Muller invented Lupuzor�, there are no serious side effects to the patient whilst taking the drug, and ImmuPharma has confirmed many times that we are talking to potential partners" Once we have full data from the study, and evaluated it further we will release to the market Not more to say on this.... As I have said before, once we have full data from the study, we will release to the market

for 13p a share.... ?

That the company is going in the right direction, but it is going to be a long haul. The impairment is a bit worrying, they will need more money, so another dilution is forthcoming and we do not know how much the leak is going to cost them

That is what is going on Watch this space

something in the region of 1b euros, do they up their stake ?

This coming week, game changer .....

This agreement with Sanderson was agreed 10 days ago. We cannot go in to any more detail other than to say that this agreement was done 10 days ago.

Not insider information at all - nothing has been signed yet, today, maybe tomorrow......!!

They have already a dialogue with the ministry and have brokered "many a deal" behind the scenes with two big companies based in the US already Having them on board is an incredible achievement for KIBO, and for them to take shares at the 5p level, makes this investment even more compelling

https://www.investegate.co.uk/motif-bio-plc--mtfb-/rns/revive-2-study-results-published-in-journal/201805010700076359M/

We see in the short term the stock eclipsing this level. TP 1.6p

trading the bands

Not true. Subset data is separate data from people who left the trial early The signs are that Lupuzor OUTPERFORMED Placebo substantially, and this has been found after mining the data further.

We are hearing that there could be an announcement shortly concerning more information pertaining to the data announcement on Tuesday where in fact the data is better than first found and that in fact Lupuzor has worked far better than the initial results showed and that the "placebo" is in fact "far less"

https://m.nasdaq.com/press-release/paratek-pharmaceuticals-inc-prices-140-million-of-convertible-senior-subordinated-notes-due-2024-20180419-00711